<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[University of Pennsylvania Medical Ethics & Health Policy | Events]]></title><description><![CDATA[Upcoming public events from the Medical Ethics & Health Policy program]]></description><link>http://medethicshealthpolicy.upenn.edu</link><image><url>http://medethicshealthpolicy.upenn.edu/images/medethics-og.png</url><title>University of Pennsylvania Medical Ethics &amp; Health Policy | Events</title><link>http://medethicshealthpolicy.upenn.edu</link></image><generator>RSS for Node</generator><lastBuildDate>Sun, 17 May 2026 02:11:53 GMT</lastBuildDate><atom:link href="http://medethicshealthpolicy.upenn.edu/events/rss" rel="self" type="application/rss+xml"/><pubDate>Invalid Date</pubDate><copyright><![CDATA[2017 University of Pennsylvania]]></copyright><language><![CDATA[en]]></language><managingEditor><![CDATA[University of Pennsylvania Medical Ethics & Health Policy]]></managingEditor><ttl>60</ttl><item><title><![CDATA[Penn Bioethics Seminar (PBS): "Organ Diversion or Match Run Deviation? Ethical Considerations in Allocation Out of Sequence" - Andrew M. Courtwright, MD, PhD | May 19th 2026, 12:00:00 pm]]></title><description><![CDATA[
Organ Diversion or Match Run Deviation? Ethical Considerations in Allocation Out of Sequence

 
 
Andrew M. Courtwright, MD, PhD
 
Clinician, Division of Pulmonary Medicine

Adjunct Professor, University of Utah Department of Philosophy

University of Utah Health
 
The rise of Allocation Out of Sequence (AOOS) in organ transplantation in the United States has raised significant ethical concerns. By the end of 2024, 20% of kidneys were transplanted out of the standard match sequence, drawing regulatory scrutiny. Critics argue that AOOS amounts to organ diversion: it fails to prevent organ nonuse, does not address underlying inefficiencies in organ allocation, lacks transparency, and worsens transplant-related disparities.



In this talk, Dr. Courtwright discusses the factors contributing to the expansion of AOOS and evaluates the normative arguments for and against its use.  Drawing on a constructivist framework, he argues that AOOS violates the expectation that allocation policies be grounded in collective agreement. Dr. Courtwright identifies considerations that should inform Organ Procurement and Transplantation Network policy revisions, emphasizing the need for shared norms to ensure procedural legitimacy.
]]></description><link>http://medethicshealthpolicy.upenn.edu//master-of-bioethics/new-students/alumni-colloquium-series-2022-23/penn-bioethics-seminar-pbs-organ-diversion-or-match-run-deviation-ethical-considerations-in-allocation-out-of-sequence-andrew-m-courtwright-md-phd</link><guid isPermaLink="true">http://medethicshealthpolicy.upenn.edu//master-of-bioethics/new-students/alumni-colloquium-series-2022-23/penn-bioethics-seminar-pbs-organ-diversion-or-match-run-deviation-ethical-considerations-in-allocation-out-of-sequence-andrew-m-courtwright-md-phd</guid><pubDate>Invalid Date</pubDate></item><item><title><![CDATA[Research Ethics & Policy Series (REPS): Returning Results to Participants in Pragmatic Trials - Catherine Auriemma, MD, MSHP | June 2nd 2026, 12:00:00 pm]]></title><description><![CDATA[
Returning Results to Participants in Pragmatic Trials
 


Catherine Auriemma, MD, MSHP
 
Assistant Professor of Medicine

division of Pulmonary, Allergy, and Critical Care

Core Faculty at the PAIR Center

University of Pennsylvania
 
Funders and regulators are increasingly requiring investigators to return study results to research participants. Return of research results is thought to improve trust and engender future participation in research. However, evidence for the benefits of returning results is primarily in study designs that include individual informed consent. Pragmatic clinical trials, a key approach to conducing comparative effectiveness research in real-world clinical-care settings, are often conducted with waivers of individual informed consent. As a result, individuals are generally unaware of their research participation. We will discuss what is known (and not known) about the optimal approach to returning research results in such contexts.



Registration required; Lunch provided.

Streaming available via Zoom.
]]></description><link>http://medethicshealthpolicy.upenn.edu//master-of-bioethics/new-students/alumni-colloquium-series-2022-23/research-ethics-policy-series-reps-returning-results-to-participants-in-pragmatic-trials-catherine-auriemma-md-mshp</link><guid isPermaLink="true">http://medethicshealthpolicy.upenn.edu//master-of-bioethics/new-students/alumni-colloquium-series-2022-23/research-ethics-policy-series-reps-returning-results-to-participants-in-pragmatic-trials-catherine-auriemma-md-mshp</guid><pubDate>Invalid Date</pubDate></item><item><title><![CDATA[Penn Bioethics Seminar (PBS): "Commercial Neurotechnologies and the Risks of Cognitive Warfare” - Łukasz Kamieński, PhD, MSc | June 16th 2026, 12:00:00 pm]]></title><description><![CDATA[
 Łukasz Kamieński, PhD, MSc
 


Professor

International and Political Studies

Jagiellonian University, Krakow
 
Consumer neurotechnology, especially wearable brain-monitoring devices and non-invasive brain-computer interfaces, is moving beyond therapy into wellness, entertainment, and productivity, with major technology companies and start-ups investing in everyday applications. EEG- and ultrasound-based wearables are designed to detect cognitive states, including alertness, attention, stress, and mood. As these products are integrated into headbands, earbuds, and headphones, neurodata collection becomes ambient and continuous.


Neuroethical discussions usually emphasize mental privacy, autonomy, and liberty, yet national security remains an overlooked aspect. Neurodata may support personalized neuromarketing, but it can also enable hostile influence operations by turning consumer devices into platforms for “cognitive warfare.” This concept refers to unconventional conflict in which adversaries target the human mind by shaping perceptions, beliefs, and decision-making.


Neurodata may flow across platforms, cloud services, and jurisdictions in ways that remain opaque to users. Such transfers can enable third-party access without meaningful awareness or consent and may evade effective state oversight. When combined with other biometric information, including digital fingerprints, neurodata can enhance AI-driven psychological and sentiment profiling.


Neurodata-enabled microtargeting, therefore, marks a significant shift in cognitive warfare, making the protection of the cognitive domain both an ethical and a strategic imperative.
]]></description><link>http://medethicshealthpolicy.upenn.edu//master-of-bioethics/new-students/alumni-colloquium-series-2022-23/penn-bioethics-seminar-pbs-commercial-neurotechnologies-and-the-risks-of-cognitive-warfare-łukasz-kamieński-phd-msc</link><guid isPermaLink="true">http://medethicshealthpolicy.upenn.edu//master-of-bioethics/new-students/alumni-colloquium-series-2022-23/penn-bioethics-seminar-pbs-commercial-neurotechnologies-and-the-risks-of-cognitive-warfare-łukasz-kamieński-phd-msc</guid><pubDate>Invalid Date</pubDate></item><item><title><![CDATA[Penn Bioethics Seminar (PBS): "Medical and Scientific Construction(s) of Race: A History in Brief" - Rana A. Hogarth, PhD, MHS | June 23rd 2026, 12:00:00 pm]]></title><description><![CDATA[
Medical and Scientific Construction(s) of Race: A History in Brief

 
 
Rana A. Hogarth, PhD, MHS
 
Associate Professor

History of Science / History of Medicine

University of Pennsylvania
 
                Deans' Distinguished Visiting Professorship Program
 
Rana A. Hogarth holds a Ph.D. in History, with a concentration in History of Science/History of Medicine from Yale University. She also holds an M.H.S. in Health Policy from the Johns Hopkins Bloomberg School of Public Health. Her work focuses on medical and scientific constructions of race during the era of slavery and beyond. Her scholarship brings together the fields of African American History, History of Medicine, and Atlantic World History.


More detail to follow.
]]></description><link>http://medethicshealthpolicy.upenn.edu//master-of-bioethics/new-students/alumni-colloquium-series-2022-23/penn-bioethics-seminar-pbs-medical-and-scientific-construction-s-of-race-a-history-in-brief-rana-a-hogarth-phd-mhs</link><guid isPermaLink="true">http://medethicshealthpolicy.upenn.edu//master-of-bioethics/new-students/alumni-colloquium-series-2022-23/penn-bioethics-seminar-pbs-medical-and-scientific-construction-s-of-race-a-history-in-brief-rana-a-hogarth-phd-mhs</guid><pubDate>Invalid Date</pubDate></item></channel></rss>